Correlation between chronic low-grade inflammation and glucose and lipid metabolism indicators in polycystic ovary syndrome

References

• Norman RJ, Dewailly D, Legro RS, et al. Polycystic ovary syndrome. Lancet. 2007;370(9588):1–5. doi: 10.1016/S0140-6736(07)61345-2.
   PubMed Web of Science ®Google Scholar
• Yang R, Li Q, Zhou Z, et al. Changes in the prevalence of polycystic ovary syndrome in China over the past decade. Lancet Reg Health West Pac. 2022;25:100494. doi: 10.1016/j.lanwpc.2022.100494.
   PubMedGoogle Scholar
• Haddad-Filho H, Tosatti JAG, Vale FM, et al. Updates in diagnosing polycystic ovary syndrome-related infertility. Expert Rev Mol Diagn. 2023;23(2):123–132. doi: 10.1080/14737159.2023.2177536.
   PubMed Web of Science ®Google Scholar
• Guo F, Gong Z, Fernando T, et al. The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: a retrospective study in chinese population. Front Endocrinol (Lausanne). 2022;13:892125. doi: 10.3389/fendo.2022.892125.
   PubMed Web of Science ®Google Scholar
• Caserta D, Adducchio G, Picchia S, et al. Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping. Gynecol Endocrinol. 2014;30(6):397–402. doi: 10.3109/09513590.2014.887673.
   PubMed Web of Science ®Google Scholar
• Sadeghi HM, Adeli I, Calina D, et al. Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. IJMS. 2022;23(2):583. doi: 10.3390/ijms23020583.
   Google Scholar
• Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: what’s new? Adv Clin Exp Med. 2017;26(2):359–367. doi: 10.17219/acem/59380.
   PubMed Web of Science ®Google Scholar
• Ganie MA, Vasudevan V, Wani IA, et al. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J Med Res. 2019;150(4):333–344. doi: 10.4103/ijmr.IJMR_1937_17.
   PubMed Web of Science ®Google Scholar
• Thomann R, Rossinelli N, Keller U, et al. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome. Gynecol Endocrinol. 2009;24(4):199–206. doi: 10.1080/09513590801893398.
   Web of Science ®Google Scholar
• Abraham Gnanadass S, Divakar Prabhu Y, Valsala Gopalakrishnan A. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet. 2021;303(3):631–643. doi: 10.1007/s00404-020-05951-2.
   PubMed Web of Science ®Google Scholar
• Rudnicka E, Suchta K, Grymowicz M, et al. Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci. 2021;22(7):3789. doi: 10.3390/ijms22073789.
   PubMed Web of Science ®Google Scholar
• Stefanaki C, Pervanidou P, Boschiero D, et al. Chronic stress and body composition disorders: implications for health and disease. Hormones (Athens. 2018;17(1):33–43.). doi: 10.1007/s42000-018-0023-7.
   PubMedGoogle Scholar
• Luan YY, Zhang L, Peng YQ, et al. Immune regulation in polycystic ovary syndrome. Clin Chim Acta. 2022;531:265–272. doi: 10.1016/j.cca.2022.04.234.
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism. 2019;92:108–120. doi: 10.1016/j.metabol.2018.11.002.
   PubMed Web of Science ®Google Scholar
• Rotterdam EA-SPCWG. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
   Web of Science ®Google Scholar
• Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6–15. doi: 10.1016/j.fertnstert.2016.05.003.
   PubMed Web of Science ®Google Scholar
• Xu Y, Qiao J. Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature. J Healthc Eng. 2022;20222022::9240569. doi: 10.1155/2022/9240569.
   PubMed Web of Science ®Google Scholar
• Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2011;17(1):17–33. doi: 10.1093/humupd/dmq032.
   PubMed Web of Science ®Google Scholar
• Wei D, Shi Y, Li J, et al. Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome. Hum Reprod. 2017;32(2):354–361. doi: 10.1093/humrep/dew325.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu H, Li Z, et al. The release of peripheral immune inflammatory cytokines promote an inflammatory Cascade in PCOS patients via altering the follicular microenvironment. Front Immunol. 2021;12:685724. doi: 10.3389/fimmu.2021.685724.
   PubMed Web of Science ®Google Scholar
• Wekker V, van Dammen L, Koning A, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020;26(6):942–960. doi: 10.1093/humupd/dmaa029.
   PubMed Web of Science ®Google Scholar
• Armanini D, Boscaro M, Bordin L, et al. Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci. 2022;23(8):4110. doi: 10.3390/ijms23084110.
   PubMed Web of Science ®Google Scholar
• Schmidt J, Weijdegård B, Mikkelsen AL, et al. Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women. Mol Hum Reprod. 2014;20(1):49–58. doi: 10.1093/molehr/gat051.
   PubMed Web of Science ®Google Scholar
• Aboeldalyl S, James C, Seyam E, et al. The role of chronic inflammation in polycystic ovarian syndrome—a systematic review and Meta-Analysis. Int J Mol Sci. 2021;22(5):2734. doi: 10.3390/ijms22052734.
   PubMed Web of Science ®Google Scholar
• Snider AP, Wood JR. Obesity induces ovarian inflammation and reduces oocyte quality. Reproduction. 2019;158(3):R79–R90. doi: 10.1530/REP-18-0583.
   PubMed Web of Science ®Google Scholar
• Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. 2010;2010:1–10. doi: 10.1155/2010/289645.
   Web of Science ®Google Scholar
• Sargın MA, Yassa M, Taymur BD, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: are they useful for predicting gestational diabetes mellitus during pregnancy? Ther Clin Risk Manag. 2016;12:657–665. doi: 10.2147/TCRM.S104247.
   PubMed Web of Science ®Google Scholar
• Rudnicka EK, Suchta K, Machura P, et al. Inflammatory markers in women with polycystic ovary syndrome. Biomed Res Int. 2020;2020:4092470–4092410. doi: 10.1155/2020/4092470.
   PubMed Web of Science ®Google Scholar
• Almaeen AH, Alduraywish AA, Nabi M, et al. Quantitative changes in white blood cells: correlation with the hallmarks of polycystic ovary syndrome. Medicina. 2022;58(4):535. doi: 10.3390/medicina58040535.
   PubMedGoogle Scholar